Mar 29, 2016 10:02AM BioLineRx's (BLRX) BL-8040's Phase 2 Data is Encouraging; Roth Affirms at 'Buy'

Mar 22, 2016 08:45AM Roth Positive on BioLineRx (BLRX) Ahead of Phase 2a AML Data; Reaffirms at 'Buy'

Mar 10, 2016 02:10PM Roth Affirms BioLineRx (BLRX) at 'Buy'; Top-Line Data on '8040 in r/rAML Remains in Focus

Jan 12, 2016 11:25AM Roth Positive on BioLineRx (BLRX) and Merck's BL-8040 + KEYTRUDA Collaboration

Nov 5, 2015 12:19PM Streetinsider.com's Hot Lunchtime Reads 11/5: (VRX) (CAB) (QCOM) (BLRX) (RNWK)

Nov 5, 2015 11:51AM BioLineRx's (BLRX) Latest BL-8040 Phase 2 Data in r/r AML is 'Intriguing' - Roth Capital

Aug 20, 2015 12:40PM Roth Capital Affirms BioLineRx (BLRX) at 'Buy' Following Q2 Results; BL-8040 Continues to be Main Driver

Aug 17, 2015 09:48AM Roth Capital Positive on BioLineRx (BLRX) Following BL-8040 Phase 2b Initiation

Jul 27, 2015 09:30AM Roth Capital Cuts Price Target on BioLineRx (BLRX) to $7 Following Data Results

Jul 15, 2015 12:09PM Streetinsider.com's Hot Lunchtime Reads 7/15: (M) (BLRX) (ARCP) (TBT)

Jul 15, 2015 10:56AM BioLineRx (BLRX) Bullish Stance Reiterated at Roth Capital Ahead of Data Release

Jun 22, 2015 01:57PM Roth Capital Previews Preclinical PRESERVATION-1 Data; Affirms BioLineRx (BLRX) at 'Buy'

May 4, 2015 08:55AM Roth Capital Affirms BioLineRx (BLRX) at 'Buy' Following BL-8040 Update

Mar 25, 2015 09:45AM BioLineRx's (BLRX) BL-8040 Better Positioned as SOC Alternate in SC Mobilization - Roth Capital

Mar 23, 2015 02:03PM PRESERVATION I Study is Key Upcoming Milestone for BioLineRx (BLRX); Roth Affirms at 'Buy'

Mar 6, 2015 09:05AM BioLineRx (BLRX) Prices 12.5M Public Offering at $2/ADS

Jan 14, 2015 04:20PM Readout of PRESENTATION I Remains Major Catalyst for BioLineRx (BLRX) in FY15 - Roth Capital

Jan 6, 2015 02:21PM BioLineRx (BLRX) Continues Executing Well on BL-8040; Roth Capital Affirms at 'Buy'

Dec 24, 2014 08:52AM Roth 'Encouraged' by Progress, Biz Development of BioLineRx's (BLRX) BL-5010; Affirms 'Buy' Rating

Dec 15, 2014 08:27AM Roth Capital Lifts PT on BioLineRx (BLRX) to $10.50 Following Investor Day; BL-8040 in AML Remains Promising

Dec 12, 2014 03:33PM Roth Keeps BioLineRx (BLRX) at 'Buy'; Sees BL-8040 Plan Progressing Nicely Following Recent Update

Dec 8, 2014 11:22AM Roth 'Encouraged' by Early Signs of BL-8040 Activity in AML; Affirms BioLineRx at 'Buy'

Nov 3, 2014 11:44AM Roth 'Encouraged' by Initial BL-8040 Safety, Pharmacodynamic Data; Maintains BioLineRx (BLRX) at 'Buy'

Sep 29, 2014 12:04PM Streetinsider.com's Hot Lunchtime Reads 9/29: (AAPL) (JACK) (BLRXX) (TSLA)

Sep 29, 2014 11:27AM Daiichi Sankyo, Ambit (AMBI) Deal is Positive for BioLineRx (BLRX) - Roth Capital

Sep 17, 2014 12:16PM Streetinsider.com's Hot Lunchtime Reads 9/17: (ATVI) (NKE) (AAPL) (BLRX)

Sep 17, 2014 11:25AM Preclinical BioLineRx (BLRX) BL-8040 Data on AML is Encouraging - Roth Capital

Sep 3, 2014 11:39AM Roth Remains Positive on BioLineRx (BLRX); Dosing of BL-8040 Phase 1 Initiated

Aug 21, 2014 09:35AM Roth Capital Comments on BioLineRx (BLRX) Following NoA for BL-7010; Sees Additional Milestones Approaching

Jul 2, 2014 09:27AM Roth Reinstates BioLineRx (BLRX) at 'Buy'; Strong Pipeline Reinforces Upside Potential

Jul 2, 2014 08:44AM Roth Capital Resumes BioLineRx (BLRX) at Buy

Mar 7, 2014 12:07PM BioLineRx (BLRX) Closes 9.66M ADS Offering for Gross Proceeds of $24.1M

Mar 4, 2014 09:04AM BioLineRx (BLRX) Prices 8.4M Offering at $2.50/ADS

Mar 3, 2014 05:55PM BioLineRx (BLRX) Lower on Stock Offering